» Authors » Manel Mendoza

Manel Mendoza

Explore the profile of Manel Mendoza including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 219
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Manau P, Bonacina E, Martin-Alonso R, Martin L, Palacios A, Sanchez-Camps M, et al.
Nat Med . 2025 Jan; PMID: 39775039
Small fetuses, with estimated fetal weight (EFW) below the tenth percentile, are classified as fetal growth restriction (FGR) or small for gestational age (SGA) based on prenatal ultrasound. FGR fetuses...
2.
Gascon A, Maiz N, Brik M, Mendoza M, Del Barco E, Carreras E, et al.
Eur J Obstet Gynecol Reprod Biol X . 2024 Nov; 24:100347. PMID: 39497908
Objective: Cervical insufficiency accounts for 8 % of preterm births. Pessary and cerclage are considered preventive approaches for preterm birth. These interventions were compared in terms of reducing the prematurity...
3.
Ricart M, Bonacina E, Garcia-Manau P, Lopez M, Caamina S, Vives A, et al.
Acta Obstet Gynecol Scand . 2024 Aug; 103(11):2273-2280. PMID: 39171611
Introduction: This study aims to evaluate the safety of discontinuing aspirin treatment at 24-28 weeks in women at high risk after first-trimester combined screening for preeclampsia (PE) and normal placental...
4.
Mendoza M, Bonacina E, Carreras E, Suy A
BJOG . 2024 Jan; 131(4):528-529. PMID: 38225915
No abstract available.
5.
Giralt M, Diaz-Troyano N, Comas I, Blanco A, Conesa L, Mendoza M, et al.
Ann Clin Biochem . 2023 Nov; 61(4):284-290. PMID: 37996255
Background: Gestational hypothyroidism has been shown to be associated with adverse pregnancy outcomes as well as adverse outcomes for the child. Thyroid hormones concentrations change in gestation, especially within the...
6.
Garcia-Manau P, Bonacina E, Serrano B, Caamina S, Ricart M, Lopez-Quesada E, et al.
Acta Obstet Gynecol Scand . 2023 Oct; 102(12):1711-1718. PMID: 37814344
Introduction: Pre-eclampsia affects 2%-8% of pregnancies and is one of the leading causes of maternal and perinatal morbidity and mortality. First-trimester screening using an algorithm that combines maternal characteristics, mean...
7.
Bonacina E, Garcia-Manau P, Lopez M, Caamina S, Vives A, Lopez-Quesada E, et al.
BJOG . 2023 Aug; 131(3):334-342. PMID: 37555464
Objective: To assess whether aspirin treatment can be discontinued in pregnancies with normal uterine artery pulsatility index (≤90th percentile) at 24-28 weeks. Design: Post-hoc analysis of a clinical trial. Setting:...
8.
Mendoza M, Carreras E, Suy A
JAMA . 2023 Jun; 329(22):1988-1989. PMID: 37314277
No abstract available.
9.
Del Barco E, Franco-Jarava C, Vargas M, Maiz N, Arevalo S, Sanchez M, et al.
Acta Obstet Gynecol Scand . 2023 Mar; 102(4):480-485. PMID: 36906815
Introduction: Nowadays, proinflammatory factors are considered to play an important role in the pathophysiology of threatened preterm labor or chorioamnionitis. The aim of this study was to establish the normal...
10.
Mendoza M, Bonacina E, Garcia-Manau P, Lopez M, Caamina S, Vives A, et al.
JAMA . 2023 Feb; 329(7):542-550. PMID: 36809321
Importance: Aspirin reduces the incidence of preterm preeclampsia by 62% in pregnant individuals at high risk of preeclampsia. However, aspirin might be associated with an increased risk of peripartum bleeding,...